Answers are grounded in this paper and cite their sources.
Progress in medical and scientific research has increased the chances of survival for young patients with congenital diseases, children who, in the past, would not have had any chance of survival. Nowadays, congenital diseases can be treated with appropriate replacement therapies. These treatments can be difficult to administer in young patients because of the high frequency of administration (sometimes more than a dose per week), the use of intravenous infusion and the long-term or life-term requirement.
No takes yet. Share an insight, caveat, or question.
Caruselli et al. (2012) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: